FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENT
BCL11B 在淋巴细胞定型中的作用基因组学和机制
基本信息
- 批准号:9914203
- 负责人:
- 金额:$ 63.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-04 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcuteAffectBindingBinding SitesBiologicalCRISPR/Cas technologyCell LineageCellsChIP-seqChromatinChromatin LoopClustered Regularly Interspaced Short Palindromic RepeatsComplexDNADNA BindingDefectDevelopmentDevelopmental GeneDevelopmental ProcessDiagnosisDiseaseDissectionE proteinGene ExpressionGene Expression ProfileGene Expression RegulationGenesGenetic Predisposition to DiseaseGenetic TranscriptionGenetic studyGenomeGenome MappingsGenomic SegmentGenomic approachGenomicsHuman GeneticsID2 geneImmuneImmune systemInvestmentsKnock-outKnockout MiceLightLinkLocationLymphocyteLymphoid CellMapsMature T-LymphocyteMediatingMolecularNatural Killer CellsNuclear Hormone ReceptorsOutputPatternPropertyProteomicsRadiationRegulationRegulator GenesResearch PersonnelResolutionResourcesRoleSiteSystemT-Cell DevelopmentT-Cell LymphomaT-LymphocyteT-Lymphocyte SubsetsTechniquesTestingTimeTranscriptional RegulationWorkZinc Fingersalpha-beta T-Cell Receptorcell typechicken ovalbumin upstream promoter-transcription factorcofactorfunctional genomicsgenetic corepressorgenome-wideleukemialoss of functionpreferenceprotein complexprotein functionrecruitretroviral transductiontranscription factor
项目摘要
ABSTRACT/PROJECT SUMMARY
Bcl11b is a bifunctional zinc finger transcription factor that is crucial for the lineage commitment of TCRαβ T
cells. The Bcl11b gene is activated precisely at the developmental transition when the cells undergo
commitment, and it sustains αβ T-cell identity and functions of multiple T-cell subsets thereafter. Genes that it
keeps silent during initial T-cell commitment include key regulators of all innate lymphoid cells (ILCs) and natural
killer cells (NK). Some of these genes are also continuously repressed by Bcl11b in mature T cells. However,
surprisingly, Bcl11b is also expressed in one particular class of innate lymphoid cells, ILC2 cells. ILC2 cells also
require Bcl11b for their identity, yet at the same time, they express Bcl11b along with Id2 and other genes that
Bcl11b normally silences in T cells. A major question is how Bcl11b works so differently in ILC2 and early
developing T cells (pro-T cells). We propose to determine how this works using functional genomics and gene
network dissection to shed light on the mechanisms that make the difference.
Our preliminary evidence from ChIP-seq and proteomic analyses shows that Bcl11b binds to distinct, only
partially overlapping sets of sites in the two cellular contexts, and interacts with different transcriptional partners;
and this is correlated with regulation of almost completely nonoverlapping sets of Bcl11b-sensitive genes in the
two contexts. To interpret these differences, we first distinguish functional from probably-nonfunctional sites
where Bcl11b binds DNA, by identifying its impact on complexes of co-regulators that assemble with it. Thus,
the subset of sites is mapped where Bcl11b has a locally indispensable nucleation role for chromatin-modulating
cofactors and/or other specific interaction partners. Second, we plan to map genomic regions where higher-order
chromatin looping interactions and compartment boundaries can also be shown to depend on Bcl11b expression.
These results will identify the Bcl11b binding sites in each cell context where that binding is molecularly
functional. To determine the underlying causes of these differences, we will test how Bcl11b's own site binding
preferences may be established through the presence of other transcription factors. We have identified at least
two other important sequence-specific transcription factors, e.g., that (1) interact extensively with Bcl11b at many
of its binding sites in the T-cell context, yet (2) are under-represented in ILC2 cells. Using retroviral transduction
and CRISPR technology adapted to pro-T cells, we will introduce or delete putative interaction partners
reciprocally in ILC2 and pro-T cells, to evaluate critically what roles they may have in guiding the binding and
function of Bcl11b. We will apply this approach to explain how Bcl11b nucleates functionally different sites in
pro-T cells and ILC2s. Finally, an interaction of particular importance is the gene network circuit through which
we have shown Bcl11b to support E proteins in establishing the T-lineage commitment regulatory state. Using
conditional double knockouts, we will resolve the subsets of Bcl11b gene regulation effects that are mediated
through this circuit from those that are controlled directly.
摘要/项目摘要
Bcl11b 是一种双功能锌指转录因子,对于 TCRαβ T 的谱系定型至关重要
细胞。 Bcl11b 基因在细胞经历发育转变时被精确激活。
承诺,并且此后它维持 αβ T 细胞身份和多个 T 细胞亚群的功能。基因表明它
在最初的 T 细胞定向过程中保持沉默的因素包括所有先天淋巴细胞 (ILC) 和天然淋巴细胞的关键调节因子
杀伤细胞(NK)。其中一些基因也在成熟 T 细胞中被 Bcl11b 持续抑制。然而,
令人惊讶的是,Bcl11b 也在一类特定的先天淋巴细胞 ILC2 细胞中表达。 ILC2细胞也
需要 Bcl11b 来确定其身份,但同时,它们也表达 Bcl11b 以及 Id2 和其他基因,这些基因
Bcl11b 通常在 T 细胞中沉默。一个主要问题是 Bcl11b 在 ILC2 和早期的工作方式有何不同?
发育中的 T 细胞(前 T 细胞)。我们建议使用功能基因组学和基因来确定其工作原理
网络剖析以揭示产生差异的机制。
我们来自 ChIP-seq 和蛋白质组学分析的初步证据表明,Bcl11b 仅与不同的结合
两个细胞环境中部分重叠的位点组,并与不同的转录伙伴相互作用;
这与 Bcl11b 敏感基因组几乎完全不重叠的调节相关
两个上下文。为了解释这些差异,我们首先区分功能性站点和可能非功能性站点
Bcl11b 与 DNA 结合,通过识别其对与其组装的共调节因子复合物的影响。因此,
绘制了 Bcl11b 位点子集,其中 Bcl11b 对染色质调节具有局部不可缺少的成核作用
辅助因子和/或其他特定的相互作用伙伴。其次,我们计划绘制高阶基因组区域图谱
染色质环相互作用和区室边界也取决于 Bcl11b 表达。
这些结果将识别每个细胞环境中的 Bcl11b 结合位点,其中该结合是分子上的
功能性的。为了确定这些差异的根本原因,我们将测试 Bcl11b 自身的位点结合方式
偏好可以通过其他转录因子的存在来建立。我们至少确定了
另外两个重要的序列特异性转录因子,例如 (1) 在许多方面与 Bcl11b 广泛相互作用
其在 T 细胞环境中的结合位点,但 (2) 在 ILC2 细胞中代表性不足。使用逆转录病毒转导
和适应亲T细胞的CRISPR技术,我们将引入或删除假定的相互作用伙伴
在 ILC2 和 pro-T 细胞中相互相互作用,以批判性地评估它们在指导结合和
Bcl11b 的功能。我们将应用这种方法来解释 Bcl11b 如何在功能上不同的位点上成核
pro-T 细胞和 ILC2。最后,一个特别重要的相互作用是基因网络电路,通过它
我们已经证明 Bcl11b 支持 E 蛋白建立 T 谱系承诺调节状态。使用
条件双敲除,我们将解析所介导的 Bcl11b 基因调控效应的子集
通过该电路直接控制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN V. ROTHENBERG其他文献
ELLEN V. ROTHENBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN V. ROTHENBERG', 18)}}的其他基金
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
pro-T 细胞中的 Lmo2-Lyl1 和 bHLH 因子网络
- 批准号:
10427443 - 财政年份:2021
- 资助金额:
$ 63.23万 - 项目类别:
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
pro-T 细胞中的 Lmo2-Lyl1 和 bHLH 因子网络
- 批准号:
10624261 - 财政年份:2021
- 资助金额:
$ 63.23万 - 项目类别:
Lmo2-Lyl1 and the bHLH factor network in pro-T cells
pro-T 细胞中的 Lmo2-Lyl1 和 bHLH 因子网络
- 批准号:
10299482 - 财政年份:2021
- 资助金额:
$ 63.23万 - 项目类别:
System dynamics and gene network architecture of early T-cell development
早期 T 细胞发育的系统动力学和基因网络架构
- 批准号:
10380658 - 财政年份:2019
- 资助金额:
$ 63.23万 - 项目类别:
System dynamics and gene network architecture of early T-cell development
早期 T 细胞发育的系统动力学和基因网络架构
- 批准号:
9978118 - 财政年份:2019
- 资助金额:
$ 63.23万 - 项目类别:
System dynamics and gene network architecture of early T-cell development
早期 T 细胞发育的系统动力学和基因网络架构
- 批准号:
10617258 - 财政年份:2019
- 资助金额:
$ 63.23万 - 项目类别:
FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENT
BCL11B 在淋巴细胞定型中的作用基因组学和机制
- 批准号:
10393519 - 财政年份:2018
- 资助金额:
$ 63.23万 - 项目类别:
Genomic site binding rules and regulatory factor function in developing T cells
发育中 T 细胞的基因组位点结合规则和调节因子功能
- 批准号:
8692996 - 财政年份:2013
- 资助金额:
$ 63.23万 - 项目类别:
Genomic site binding rules and regulatory factor function in developing T cells
发育中 T 细胞的基因组位点结合规则和调节因子功能
- 批准号:
8560062 - 财政年份:2013
- 资助金额:
$ 63.23万 - 项目类别:
Genomic site binding rules and regulatory factor function in developing T cells
发育中 T 细胞的基因组位点结合规则和调节因子功能
- 批准号:
9256523 - 财政年份:2013
- 资助金额:
$ 63.23万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 63.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 63.23万 - 项目类别:
Standard Grant














{{item.name}}会员




